Innovative Radiopharmaceuticals in Oncology and Neurology
Dublin Core
Title
Innovative Radiopharmaceuticals in Oncology and Neurology
Subject
Oncology and Neurology
Description
Personalized medicine is presented as the future of patient care. Nuclear Medicine will play a major role in the selection of patients for targeted therapies and in early therapy assessment with the investigation of phenotypes and functions using sensitive and specific SPECT and PET imaging techniques and theranostic approaches. Nuclear Medicine is already a key in the development of new therapies and targeted radionuclide therapy provides efficacious treatment modalities against cancer. An incredible amount of innovation is related to the use of a variety of radionuclides, new or improved multimodality imaging devices, and numbers of recently marketed radiopharmaceuticals in all medical domains and particularly cardiology, neurology, and oncology.
Creator
Francoise Kraeber-Bodere, et al
Source
https://www.frontiersin.org/research-topics/3871/innovative-radiopharmaceuticals-in-oncology-and-neurology
Publisher
Frontiers Media SA
Date
2017
Contributor
Baihaqi
Rights
Creative Commons
Format
PDF
Language
English
Type
Textbooks
Files
Citation
Francoise Kraeber-Bodere, et al, “Innovative Radiopharmaceuticals in Oncology and Neurology,” Open Educational Resource (OER) - USK Library, accessed April 24, 2025, http://202.4.186.74:8004/oer/items/show/2933.